4//SEC Filing
CULP H LAWRENCE JR 4
Accession 0000899243-23-001103
CIK 0001932393other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:39 PM ET
Size
12.7 KB
Accession
0000899243-23-001103
Insider Transaction Report
Form 4
CULP H LAWRENCE JR
Director
Transactions
- Award
Common stock, par value $0.01 per share
2023-01-03+580,959→ 580,959 total - Award
Deferred Fee Phantom Stock Units
2023-01-03+588→ 588 total→ Common stock, par value $0.01 per share (588 underlying) - Award
Common stock, par value $0.01 per share
2023-01-03+70,403→ 70,403 total(indirect: By holding company) - Award
Common stock, par value $0.01 per share
2023-01-03+524→ 524 total(indirect: By Trust)
Footnotes (5)
- [F1]The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.
- [F2]Represents performance shares that will vest, subject to continued service conditions and accelerated vesting in certain circumstances, based upon a weighted-average of the highest average closing price of GE's common stock and GE HealthCare's common stock for any 30 consecutive trading days during the performance period from January 3, 2023 to August 17, 2025: one-third of the performance shares will be eligible to vest upon achieving a stock price equal to 150% (the "threshold target") of the average of the closing prices of GE's common stock over the period of 30 consecutive trading days up to and including August 18, 2020 (the "30-day average price"), two-thirds of the performance shares will be eligible to vest upon achieving a stock price equal to 200% of the 30-day average price and all of the performance shares will be eligible to vest upon achieving a stock price equal to 250% (the "maximum target") of the 30-day average price.
- [F3]No performance shares will vest below the threshold target, and the amount of performance shares that vest between the threshold target and maximum target will be determined by linear interpolation.
- [F4]Each unit of phantom stock is the economic equivalent of one share of common stock of GE HealthCare.
- [F5]Award of phantom stock with respect to common stock of GE HealthCare resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off. Each award is payable beginning one year after termination of service of the reporting person. This transaction is voluntarily reported notwithstanding the exemption provided by Rule 16a-9.
Documents
Issuer
GE HealthCare Technologies Inc.
CIK 0001932393
Entity typeother
Related Parties
1- filerCIK 0001205247
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:39 PM ET
- Size
- 12.7 KB